First Light Acquisition Group, Inc. announced private placement of 2 non-convertible, zero coupon, unsecured promissory notes issued to Metric Finance Holdings III, LLC, and First Light Acquisition Group, LLC for gross proceeds of $490,000 on September 13, 2022. Note with principal amount $366,233 was issued to First Light Acquisition Group, LLC and note with principal amount $123,767 was issued to Metric Finance Holdings III, LLC. The notes will mature upon the company's business combination transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.197 USD | -1.99% | +22.59% | -86.95% |
04-16 | Calidi Biotherapeutics Prices $6.1 Million Offering | MT |
03-21 | H.C. Wainwright Lowers Price Target on Calidi Biotherapeutics to $2 From $11, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.95% | 9.64M | |
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- CLDI Stock
- News Calidi Biotherapeutics, Inc.
- First Light Acquisition Group, Inc. announced that it has received $0.49 million in funding